NAFDAC Orders Chloroquine For Clinical Trial

National Agency For Food And Drug Administration And Control (NAFDAC) has ordered a major pharmaceutical firm to manufacture Chloroquine tablets for likely clinical trial to cure Covid-19.
The agency ordered may and baker to produce it for emergency stockpiling for clinical trial.
NAFDAC Director General, Professor Mojisola Adeyeye, in a statement on Monday, said the order followed publications in China indicating the marked efficacy of chloroquine in treating Covid-19 associated pneumonia during clinical trial.
Adeyeye explained that she met with management of may and baker in Lagos four weeks ago, during which they were ordered to produce a batch of chloroquine which was once its flagship product for emergency stock.
the NAFDAC DG says the company has manufactured a batch of the drug and planned to produce more batches if needed.

 

READ ALSO]Covid 19: Makinde Tests Positive

DOWNLOAD THE ROCKCITYFM APP AND LISTEN LIVE

Please subscribe to our newsletter

CONTACT US

Do you have any request or enquiry? Do not hesitate to send us an email and we'll get back to you, asap.

Sending

©2020 RockcityFM The Voice of the People

Need Help? Chat with us
or

Log in with your credentials

or    

Forgot your details?

or

Create Account